Skip to content
healthcare.dev

RASAGILINE

NDC 13668-446, RASAGILINE, tablet, from Torrent Pharmaceuticals Limited.

Product NDC
13668-446
Status
Listed
Labeler
Torrent Pharmaceuticals Limited
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA210150
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/13668-446 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RASAGILINE MESYLATE1 mg/1

Pharmacologic classes

Monoamine Oxidase Inhibitor [EPC]; Monoamine Oxidase Inhibitors [MoA]

Package NDCNDC-11Package
13668-446-0513668044605500 TABLET in 1 CONTAINER (13668-446-05)
13668-446-301366804463030 TABLET in 1 CONTAINER (13668-446-30)
13668-446-901366804469090 TABLET in 1 CONTAINER (13668-446-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/2c5e3cde-1158-4b5a-9a2b-ea6c987a65e4
  • NADAC price for package 13668044630

    GET /v1/drugs/nadac/13668044630

Use it

Look up 13668-446 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/13668-446 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 13668-446. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.